"B monoclonal antibody" trang 1 - tải miễn phí từ tailieunhanh
Study on mixing Anti-A monoclonal antibody with Anti-B monoclonal antibody to make anti ab using for ABO blood isotyping

Study on mixing Anti-A monoclonal antibody with Anti-B monoclonal antibody to make anti ab using for ABO blood isotyping
7    97    0
Ex vivo evolution of human antibodies by CRISPR-X: From a naive B cell repertoire to affinity matured antibodies

Ex vivo evolution of human antibodies by CRISPR-X: From a naive B cell repertoire to affinity matured antibodies
13    81    0
Báo cáo khoa học: Functional analysis of a murine monoclonal antibody against the repetitive region of the fibronectin-binding adhesins fibronectin-binding protein A and fibronectin-binding protein B from Staphylococcus aureus

Báo cáo khoa học: Functional analysis of a murine monoclonal antibody against the repetitive region of the fibronectin-binding adhesins fibronectin-binding protein A and fibronectin-binding protein B from Staphylococcus aureus
16    90    0
báo cáo hóa học:

báo cáo hóa học: " Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice"
12    40    0
Báo cáo khoa học: Regulation of cathepsin B activity by 2A2 monoclonal antibody

Báo cáo khoa học: Regulation of cathepsin B activity by 2A2 monoclonal antibody
13    38    0
Báo cáo y học:

Báo cáo y học: "Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus"
15    54    0
Báo cáo y học:

Báo cáo y học: " Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collageninduced arthritis by stimulating B cels"
12    86    0
A phase II study of the PI3K inhibitor copanlisib in combination with the antiCD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: Treatment rationale and protocol design of the COUP-1 trial

A phase II study of the PI3K inhibitor copanlisib in combination with the antiCD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: Treatment rationale and protocol design of the COUP-1 trial
8    53    1